Research finds patients build a tolerance to CBD-isolated medicines

By | February 1st, 2019|Categories: CBD, Children, Dravet Syndrome, Epidiolex, Epilepsy, Interviews, Mothers, News, Parent, Patient Stories, Research, THC, UK, Uncategorised|

Research has shown patients build tolerances to CBD-isolated medicines Evidence suggests THC could potentially reduce resistance Using different strains may also help reduce CBD tolerance levels Medical cannabis was partially legalised in the UK in late 2018., but few patients have managed to obtain legal prescriptions. Among those lucky few who do have [...]

40% of American patients ditch other pharmaceutical prescription drugs for medical cannabis

By | January 21st, 2019|Categories: Cannabis, Cannabis Oil, Doctors, Legalisation, News, Opiates, Opioids, Patient Stories, Pharmaceuticals, Research, USA|

Over 2.1 million Americans have legal medical cannabis prescriptions A new University of Michigan study found that the 44% of respondent quit another drug altogether for cannabis 38% reduced the amount of a different drug they were taking Nearly one-third of medical cannabis patients don't tell their doctor of their cannabis use Yet [...]

Australian researchers launch study to test cannabis as potential treatment for brain cancer

By | January 7th, 2019|Categories: Australia, Cancer, Cannabis, Cannabis Oil, Chemotherapy, News, Research, THC, Uncategorised|

Leading Australian researchers hope to find a treatment for Glioblastoma (GBM) using medical cannabis rather than chemo or surgery GBM is the most common type of malignant brain tumour in the UK 82 participants will be given a daily dose of high THC cannabis oil over a 3 month period A leading Australian [...]

Canadian cannabis producer plans to bring down cost of CBD oil by nearly 100%

By | December 31st, 2018|Categories: Africa, Canada, Cannabis, Cannabis Oil, Cannabis Prohibiton, growing, News, Pharmaceuticals, Research|

InstaDose Pharma (IDP) is one of Canada’s largest cannabis producers CBD oil currently costs £2,188 per litre IDP plan to sell their CBD oil for £80 per litre IDP own 10,000 hectares of production land in the Democratic Republic of the Congo Canadian cannabis producer, InstaDose Pharma (IDP), plan on bringing down the [...]

UK Charity launches medical cannabis oil trial to help treat rare skin condition

By | November 28th, 2018|Categories: Cannabis, Cannabis Oil, Charity, chronic pain, News, Opiates, Opioids, Pharmaceuticals, Research, THC, UK|

A trial has been launched to see if cannabis can help treat Epidermolysis Bullosa (EB), which causes the skin to easily blister and tear The study will take place in the Netherlands, where cannabis research laws are less restrictive EB affects more than 5,000 people in the UK, causing pain and itching, with [...]

Research debunks myth that cannabis use in your youth makes you “stupid”

By | November 21st, 2018|Categories: Brain, Cannabis, IQ, Research|

Recent studies have found no causation between using cannabis and a decrease in intelligence There is still a risk for those who use cannabis “heavily” as an adolescent But no evidence to suggest using cannabis in moderation, even as a youth, leads to a drop in IQ Studies have found cannabis to actually [...]

Two new studies find opioid use lower in US states with legal cannabis

By | April 10th, 2018|Categories: Addiction, Cannabis, Cannabis Oil, chronic pain, Dispensaries, Legalisation, News, Opiates, Opioids, Pain, Research|

Two new studies found opioid use is lower when patients have access to cannabis Legalisation of medical cannabis led to a 6% drop in opioid prescriptions to Medicaid patients Legal recreational use led to additional 6% decrease: more access to cannabis = less chance of opioid addiction 64,000 people died due to opioid [...]

New Survey: No Clear Evidence Cannabis causes Schizophrenia

By | March 28th, 2018|Categories: Cannabis, Mental Health, News, Research|

Dr. Musa Sami is a British researcher at King’s College London Sami claims if cannabis caused psychosis increased rates of use would be reflected in more diagnoses Cannabis potency has increased since the 60s, yet rates of schizophrenia have stayed the same 2% of UK’s population regularly smoke cannabis (over 4 million people) [...]

New study finds CBD treats symptoms of psychosis

By | December 28th, 2017|Categories: CBD, News, Psychosis, Research, Schizophrenia|

New research suggests Cannabidiol (CBD) could be a powerful antipsychotic The clinical trial was conducted by researchers at King’s College University 220,000 people are being treated for schizophrenia in the UK by the NHS Results from the latest clinical trial on CBD found it has anti-psychotic properties and could be used in the [...]

Three game changing studies on medical cannabis

By | November 20th, 2017|Categories: Autism, Bone, Cannabis, Cannabis Oil, CBD, Chemotherapy, Children, Epidiolex, Featured Research, GW Pharma, Legalisation, Research, Research Reviews|

Words by Fergus Simpson With Cannabis now being legalised recreationally and/or medicinally in 29 states of America, and the district of Columbia, it is no surprise that there has been a whole lot more reputable research coming out onto the whiteboard. In Australia, Puerto Rico, Poland, Czech Republic, Canada, Croatia and Macedonia it is [...]